Prospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 7, 2024; 30(9): 1164-1176
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1164
Table 1 Demographic and clinical data of the study population
Parameter
Patients
Healthy control
No. of participants5917
Sex (male: female)27:329:8
Mean age (yr)41 ± 1236 ± 11
AST level (U/L)46.46 ± 68.71-
ALT level (U/L)49.86 ± 70.84-
Serum albumin (g/L)41.58 ± 5.17-
TBIL (μmol/L)22.13 ± 20.10-
Platelet (× 109/L)190.20 ± 72.88-
Table 2 Diffusion-weighted imaging-derived parameters’ means and SDs of healthy volunteers (F0) and patients with liver fibrosis stages 1-4 (F1-F4)
StagenMono-ADC (× 10-3 mm2/s)IVIM-D (× 10-3 mm2/s)IVIM-D* (× 10-3 mm2/s)IVIM-f (%)DKI-MD (× 10-3 mm2/s)DKI-MKSEM-DDC (× 10-3 mm2/s)SEM-αFROC-D (× 10-3 mm2/s)FROC-βFROC-μ (μm)CTRW-D (× 10-3 mm2/s)CTRW-αCTRW-β
0171.099 ± 0.0740.893 ± 0.0881.168 ± 0.2000.248 ± 0.0711.616 ± 0.1910.855 ± 0.1101.580 ± 0.2860.586 ± 0.0810.902 ± 0.0650.609 ± 0.0854.103 ± 0.2181.209 ± 0.0850.980 (0.973-0.994)0.551 ± 0.092
1141.134 ± 0.0810.980 ± 0.0761.135 ± 0.2990.196 ± 0.0631.554 ± 0.2000.745 ± 0.1171.540 ± 0.2700.629 ± 0.0780.946 ± 0.0610.659 ± 0.0844.011 ± 0.3681.214 ± 0.0910.987 (0.979-0.993)0.596 ± 0.095
2281.062 ± 0.0950.880 ± 0.0951.122 ± 0.2870.225 ± 0.0621.513 ± 0.1830.838 ± 0.1141.451 ± 0.2290.607 ± 0.0810.879 ± 0.0780.636 ± 0.0833.988 ± 0.3241.158 ± 0.1070.982 (0.954-0.993)0.580 ± 0.094
371.015 ± 0.1190.845 ± 0.1451.067 ± 0.1150.216 ± 0.0681.465 ± 0.1870.868 ± 0.1411.414 ± 0.2630.611 ± 0.0950.831 ± 0.1130.642 ± 0.0853.866 ± 0.2501.116 ± 0.1140.956 (0.946-0.989)0.595 ± 0.087
4101.018 ± 0.0910.860 ± 0.0721.057 ± 0.1610.201 ± 0.0421.427 ± 0.1910.825 ± 0.0661.341 ± 0.2200.633 ± 0.0400.836 ± 0.0850.663 ± 0.0423.809 ± 0.2691.110 ± 0.1190.955 (0.942-0.989)0.615 ± 0.048
F/H13.7043.9800.4181.6241.9292.4581.8300.8304.3001.0441.8202.7648.3421.003
P value0.0090.0060.7950.1780.1150.0530.1330.5110.0040.3910.1340.0340.0800.412
Table 3 Spearman correlation coefficients of diffusion-weighted imaging -derived parameters with the liver fibrosis stages
Mono-ADCIVIM-DIVIM-D*IVIM-fDKI-MDDKI-MKSEM-DDCSEM-αFROC-DFROC-βFROC-μCTRW-DCTRW-αCTRW-β
Sr value-0.362b-0.251a-0.154-0.138-0.297b0.000-0.263a0.129-0.350b0.149-0.321b-0.356b-0.297b0.199
P value0.0010.0290.1840.2330.0090.9990.0220.2680.0020.1990.0050.0020.0090.085